SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Actinium Pharmaceuticals, Inc. – ‘10-K’ for 12/31/15 – ‘XML’

On:  Friday, 3/11/16, at 5:08pm ET   ·   For:  12/31/15   ·   Accession #:  1213900-16-11534   ·   File #:  1-36374

Previous ‘10-K’:  ‘10-K’ on 3/16/15 for 12/31/14   ·   Next:  ‘10-K’ on 3/16/17 for 12/31/16   ·   Latest:  ‘10-K’ on 3/29/24 for 12/31/23   ·   4 References:   

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/11/16  Actinium Pharmaceuticals, Inc.    10-K       12/31/15   64:5.6M                                   Edgar Agents LLC/FA

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML    937K 
 2: EX-10.56    Third Amendment to the 2013 Amended and Restated    HTML     21K 
                Stock Plan, Effective as of December 22, 2015                    
 3: EX-10.57    Office Space License Agreement, Dated March 19,     HTML     73K 
                2016, by and Between Actinium Pharmaceuticals,                   
                Inc. and Relmada Therapeutics, Inc.                              
 4: EX-21.1     List of Subsidiaries                                HTML     16K 
 5: EX-23.1     Consent of Gbh CPAs, Pc.                            HTML     18K 
 6: EX-31.1     Certification -- §302 - SOA'02                      HTML     23K 
 7: EX-31.2     Certification -- §302 - SOA'02                      HTML     22K 
 8: EX-32.1     Certification -- §906 - SOA'02                      HTML     18K 
 9: EX-32.2     Certification -- §906 - SOA'02                      HTML     18K 
16: R1          Document and Entity Information                     HTML     47K 
17: R2          Consolidated Balance Sheets                         HTML     80K 
18: R3          Consolidated Balance Sheets (Parenthetical)         HTML     39K 
19: R4          Consolidated Statements of Operations               HTML     55K 
20: R5          Consolidated Statement of Changes in Stockholders'  HTML     64K 
                Equity (Deficit)                                                 
21: R6          Consolidated Statements of Cash Flows               HTML     95K 
22: R7          Description of Business and Summary of Significant  HTML     71K 
                Accounting Policies                                              
23: R8          Related Party Transactions                          HTML     45K 
24: R9          Prepaid Expenses and Other Current Assets           HTML     30K 
25: R10         Property and Equipment                              HTML     33K 
26: R11         Note Payable                                        HTML     26K 
27: R12         Derivatives                                         HTML     52K 
28: R13         Commitments and Contingencies                       HTML     58K 
29: R14         Equity                                              HTML    140K 
30: R15         Income Taxes                                        HTML     59K 
31: R16         Subsequent Events                                   HTML     29K 
32: R17         Description of Business and Summary of Significant  HTML    100K 
                Accounting Policies (Policies)                                   
33: R18         Description of Business and Summary of Significant  HTML     36K 
                Accounting Policies (Tables)                                     
34: R19         Related Party Transactions (Tables)                 HTML     22K 
35: R20         Prepaid Expenses and Other Current Assets (Tables)  HTML     28K 
36: R21         Property and Equipment (Tables)                     HTML     25K 
37: R22         Derivatives (Tables)                                HTML     50K 
38: R23         Commitments and Contingencies (Tables)              HTML     26K 
39: R24         Equity (Tables)                                     HTML     74K 
40: R25         Income Taxes (Tables)                               HTML     53K 
41: R26         Description of Business and Summary of Significant  HTML     30K 
                Accounting Policies (Details)                                    
42: R27         Description of Business and Summary of Significant  HTML     28K 
                Accounting Policies (Details 1)                                  
43: R28         Description of Business and Summary of Significant  HTML     42K 
                Accounting Policies (Details Textual)                            
44: R29         Related Party Transactions (Details)                HTML     25K 
45: R30         Related Party Transactions (Details Textual)        HTML     91K 
46: R31         Prepaid Expenses and Other Current Assets           HTML     29K 
                (Details)                                                        
47: R32         Property and Equipment (Details)                    HTML     33K 
48: R33         Property and Equipment (Details Textual)            HTML     23K 
49: R34         Note Payable (Details)                              HTML     33K 
50: R35         Derivatives (Details)                               HTML     30K 
51: R36         Derivatives (Details 1)                             HTML     38K 
52: R37         Derivatives (Details Textual)                       HTML     32K 
53: R38         Commitments and Contingencies (Details)             HTML     34K 
54: R39         Commitments and Contingencies (Details 1)           HTML     21K 
55: R40         Commitments and Contingencies (Details Textual)     HTML    114K 
56: R41         Equity (Details)                                    HTML     76K 
57: R42         Equity (Details Textual)                            HTML    275K 
58: R43         Income Taxes (Details)                              HTML     26K 
59: R44         Income Taxes (Details 1)                            HTML     55K 
60: R45         Income Taxes (Details Textual)                      HTML     26K 
61: R46         Subsequent Events (Details)                         HTML     47K 
63: XML         IDEA XML File -- Filing Summary                      XML    106K 
62: EXCEL       IDEA Workbook of Financial Reports                  XLSX     62K 
10: EX-101.INS  XBRL Instance -- atnm-20151231                       XML   1.32M 
12: EX-101.CAL  XBRL Calculations -- atnm-20151231_cal               XML     83K 
13: EX-101.DEF  XBRL Definitions -- atnm-20151231_def                XML    476K 
14: EX-101.LAB  XBRL Labels -- atnm-20151231_lab                     XML   1.17M 
15: EX-101.PRE  XBRL Presentations -- atnm-20151231_pre              XML    750K 
11: EX-101.SCH  XBRL Schema -- atnm-20151231                         XSD    179K 
64: ZIP         XBRL Zipped Folder -- 0001213900-16-011534-xbrl      Zip    125K

‘XML’   —   IDEA XML File — Filing Summary

This Document is an IDEA XML File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<FilingSummary>
<Version> 3.3.1.900 </Version>
<ProcessingTime/>
<ReportFormat> html </ReportFormat>
<ContextCount> 198 </ContextCount>
<ElementCount> 267 </ElementCount>
<EntityCount> 1 </EntityCount>
<FootnotesReported> true </FootnotesReported>
<SegmentCount> 54 </SegmentCount>
<ScenarioCount> 0 </ScenarioCount>
<TuplesReported> false </TuplesReported>
<UnitCount> 7 </UnitCount>
<MyReports>
<Report instance="atnm-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R1.htm </HtmlFileName>
<LongName> 001 - Document - Document and Entity Information </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/DocumentAndEntityInformation </Role>
<ShortName> Document and Entity Information </ShortName>
<MenuCategory> Cover </MenuCategory>
<Position> 1 </Position>
</Report>
<Report instance="atnm-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R2.htm </HtmlFileName>
<LongName> 002 - Statement - Consolidated Balance Sheets </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/ConsolidatedBalanceSheetsUnaudited </Role>
<ShortName> Consolidated Balance Sheets </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 2 </Position>
</Report>
<Report instance="atnm-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R3.htm </HtmlFileName>
<LongName> 003 - Statement - Consolidated Balance Sheets (Parenthetical) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical </Role>
<ShortName> Consolidated Balance Sheets (Parenthetical) </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 3 </Position>
</Report>
<Report instance="atnm-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R4.htm </HtmlFileName>
<LongName> 004 - Statement - Consolidated Statements of Operations </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/ConsolidatedStatementsOfOperationsUnaudited </Role>
<ShortName> Consolidated Statements of Operations </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 4 </Position>
</Report>
<Report instance="atnm-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R5.htm </HtmlFileName>
<LongName> 005 - Statement - Consolidated Statement of Changes in Stockholders' Equity (Deficit) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/ConsolidatedStatementOfChangesInStockholdersEquityDeficit </Role>
<ShortName> Consolidated Statement of Changes in Stockholders' Equity (Deficit) </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 5 </Position>
</Report>
<Report instance="atnm-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R6.htm </HtmlFileName>
<LongName> 006 - Statement - Consolidated Statements of Cash Flows </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/ConsolidatedStatementsOfCashFlowsUnaudited </Role>
<ShortName> Consolidated Statements of Cash Flows </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 6 </Position>
</Report>
<Report instance="atnm-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R7.htm </HtmlFileName>
<LongName> 007 - Disclosure - Description of Business and Summary of Significant Accounting Policies </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/DescriptionOfBusinessAndSummaryOfSignificantAccountingPolicies </Role>
<ShortName> Description of Business and Summary of Significant Accounting Policies </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 7 </Position>
</Report>
<Report instance="atnm-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R8.htm </HtmlFileName>
<LongName> 008 - Disclosure - Related Party Transactions </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/RelatedPartyTransactions </Role>
<ShortName> Related Party Transactions </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 8 </Position>
</Report>
<Report instance="atnm-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R9.htm </HtmlFileName>
<LongName> 009 - Disclosure - Prepaid Expenses and Other Current Assets </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/PrepaidExpensesAndOtherCurrentAssets </Role>
<ShortName> Prepaid Expenses and Other Current Assets </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 9 </Position>
</Report>
<Report instance="atnm-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R10.htm </HtmlFileName>
<LongName> 010 - Disclosure - Property and Equipment </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/PropertyAndEquipment </Role>
<ShortName> Property and Equipment </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 10 </Position>
</Report>
<Report instance="atnm-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R11.htm </HtmlFileName>
<LongName> 011 - Disclosure - Note Payable </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/NotePayable </Role>
<ShortName> Note Payable </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 11 </Position>
</Report>
<Report instance="atnm-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R12.htm </HtmlFileName>
<LongName> 012 - Disclosure - Derivatives </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/Derivatives </Role>
<ShortName> Derivatives </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 12 </Position>
</Report>
<Report instance="atnm-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R13.htm </HtmlFileName>
<LongName> 013 - Disclosure - Commitments and Contingencies </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/CommitmentsAndContingencies </Role>
<ShortName> Commitments and Contingencies </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 13 </Position>
</Report>
<Report instance="atnm-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R14.htm </HtmlFileName>
<LongName> 014 - Disclosure - Equity </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/Equity </Role>
<ShortName> Equity </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 14 </Position>
</Report>
<Report instance="atnm-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R15.htm </HtmlFileName>
<LongName> 015 - Disclosure - Income Taxes </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/IncomeTaxes </Role>
<ShortName> Income Taxes </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 15 </Position>
</Report>
<Report instance="atnm-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R16.htm </HtmlFileName>
<LongName> 016 - Disclosure - Subsequent Events </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/SubsequentEvents </Role>
<ShortName> Subsequent Events </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 16 </Position>
</Report>
<Report instance="atnm-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R17.htm </HtmlFileName>
<LongName> 017 - Disclosure - Description of Business and Summary of Significant Accounting Policies (Policies) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesPolicies </Role>
<ShortName> Description of Business and Summary of Significant Accounting Policies (Policies) </ShortName>
<MenuCategory> Policies </MenuCategory>
<ParentRole> http://actiniumpharmaceuticals.com/role/DescriptionOfBusinessAndSummaryOfSignificantAccountingPolicies </ParentRole>
<Position> 17 </Position>
</Report>
<Report instance="atnm-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R18.htm </HtmlFileName>
<LongName> 018 - Disclosure - Description of Business and Summary of Significant Accounting Policies (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesTables </Role>
<ShortName> Description of Business and Summary of Significant Accounting Policies (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://actiniumpharmaceuticals.com/role/DescriptionOfBusinessAndSummaryOfSignificantAccountingPolicies </ParentRole>
<Position> 18 </Position>
</Report>
<Report instance="atnm-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R19.htm </HtmlFileName>
<LongName> 019 - Disclosure - Related Party Transactions (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/RelatedPartyTransactionsTables </Role>
<ShortName> Related Party Transactions (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://actiniumpharmaceuticals.com/role/RelatedPartyTransactions </ParentRole>
<Position> 19 </Position>
</Report>
<Report instance="atnm-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R20.htm </HtmlFileName>
<LongName> 020 - Disclosure - Prepaid Expenses and Other Current Assets (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/PrepaidExpensesandOtherCurrentAssetsTables </Role>
<ShortName> Prepaid Expenses and Other Current Assets (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://actiniumpharmaceuticals.com/role/PrepaidExpensesAndOtherCurrentAssets </ParentRole>
<Position> 20 </Position>
</Report>
<Report instance="atnm-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R21.htm </HtmlFileName>
<LongName> 021 - Disclosure - Property and Equipment (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/PropertyandEquipmentTables </Role>
<ShortName> Property and Equipment (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://actiniumpharmaceuticals.com/role/PropertyAndEquipment </ParentRole>
<Position> 21 </Position>
</Report>
<Report instance="atnm-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R22.htm </HtmlFileName>
<LongName> 022 - Disclosure - Derivatives (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/DerivativesTables </Role>
<ShortName> Derivatives (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://actiniumpharmaceuticals.com/role/Derivatives </ParentRole>
<Position> 22 </Position>
</Report>
<Report instance="atnm-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R23.htm </HtmlFileName>
<LongName> 023 - Disclosure - Commitments and Contingencies (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/CommitmentsandContingenciesTables </Role>
<ShortName> Commitments and Contingencies (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://actiniumpharmaceuticals.com/role/CommitmentsAndContingencies </ParentRole>
<Position> 23 </Position>
</Report>
<Report instance="atnm-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R24.htm </HtmlFileName>
<LongName> 024 - Disclosure - Equity (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/EquityTables </Role>
<ShortName> Equity (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://actiniumpharmaceuticals.com/role/Equity </ParentRole>
<Position> 24 </Position>
</Report>
<Report instance="atnm-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R25.htm </HtmlFileName>
<LongName> 025 - Disclosure - Income Taxes (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/IncomeTaxesTables </Role>
<ShortName> Income Taxes (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://actiniumpharmaceuticals.com/role/IncomeTaxes </ParentRole>
<Position> 25 </Position>
</Report>
<Report instance="atnm-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R26.htm </HtmlFileName>
<LongName> 026 - Disclosure - Description of Business and Summary of Significant Accounting Policies (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/Descriptionofbusinessandsummaryofsignificantaccountingpoliciesdetails </Role>
<ShortName> Description of Business and Summary of Significant Accounting Policies (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://actiniumpharmaceuticals.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesTables </ParentRole>
<Position> 26 </Position>
</Report>
<Report instance="atnm-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R27.htm </HtmlFileName>
<LongName> 027 - Disclosure - Description of Business and Summary of Significant Accounting Policies (Details 1) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/Descriptionofbusinessandsummaryofsignificantaccountingpoliciesdetails1 </Role>
<ShortName> Description of Business and Summary of Significant Accounting Policies (Details 1) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://actiniumpharmaceuticals.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesTables </ParentRole>
<Position> 27 </Position>
</Report>
<Report instance="atnm-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R28.htm </HtmlFileName>
<LongName> 028 - Disclosure - Description of Business and Summary of Significant Accounting Policies (Details Textual) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesDetailsTextual </Role>
<ShortName> Description of Business and Summary of Significant Accounting Policies (Details Textual) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://actiniumpharmaceuticals.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesTables </ParentRole>
<Position> 28 </Position>
</Report>
<Report instance="atnm-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R29.htm </HtmlFileName>
<LongName> 029 - Disclosure - Related Party Transactions (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/RelatedPartyTransactionsDetails </Role>
<ShortName> Related Party Transactions (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://actiniumpharmaceuticals.com/role/RelatedPartyTransactionsTables </ParentRole>
<Position> 29 </Position>
</Report>
<Report instance="atnm-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R30.htm </HtmlFileName>
<LongName> 030 - Disclosure - Related Party Transactions (Details Textual) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/RelatedPartyTransactionsDetailsTextual </Role>
<ShortName> Related Party Transactions (Details Textual) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://actiniumpharmaceuticals.com/role/RelatedPartyTransactionsTables </ParentRole>
<Position> 30 </Position>
</Report>
<Report instance="atnm-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R31.htm </HtmlFileName>
<LongName> 031 - Disclosure - Prepaid Expenses and Other Current Assets (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/PrepaidExpensesandOtherCurrentAssetsDetails </Role>
<ShortName> Prepaid Expenses and Other Current Assets (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://actiniumpharmaceuticals.com/role/PrepaidExpensesandOtherCurrentAssetsTables </ParentRole>
<Position> 31 </Position>
</Report>
<Report instance="atnm-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R32.htm </HtmlFileName>
<LongName> 032 - Disclosure - Property and Equipment (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/PropertyandEquipmentDetails </Role>
<ShortName> Property and Equipment (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://actiniumpharmaceuticals.com/role/PropertyandEquipmentTables </ParentRole>
<Position> 32 </Position>
</Report>
<Report instance="atnm-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R33.htm </HtmlFileName>
<LongName> 033 - Disclosure - Property and Equipment (Details Textual) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/PropertyAndEquipmentDetailsTextual </Role>
<ShortName> Property and Equipment (Details Textual) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://actiniumpharmaceuticals.com/role/PropertyandEquipmentTables </ParentRole>
<Position> 33 </Position>
</Report>
<Report instance="atnm-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R34.htm </HtmlFileName>
<LongName> 034 - Disclosure - Note Payable (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/NotePayableDetails </Role>
<ShortName> Note Payable (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://actiniumpharmaceuticals.com/role/NotePayable </ParentRole>
<Position> 34 </Position>
</Report>
<Report instance="atnm-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R35.htm </HtmlFileName>
<LongName> 035 - Disclosure - Derivatives (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/DerivativesDetails </Role>
<ShortName> Derivatives (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://actiniumpharmaceuticals.com/role/DerivativesTables </ParentRole>
<Position> 35 </Position>
</Report>
<Report instance="atnm-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R36.htm </HtmlFileName>
<LongName> 036 - Disclosure - Derivatives (Details 1) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/DerivativesDetails1 </Role>
<ShortName> Derivatives (Details 1) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://actiniumpharmaceuticals.com/role/DerivativesTables </ParentRole>
<Position> 36 </Position>
</Report>
<Report instance="atnm-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R37.htm </HtmlFileName>
<LongName> 037 - Disclosure - Derivatives (Details Textual) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/DerivativesDetailsTextual </Role>
<ShortName> Derivatives (Details Textual) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://actiniumpharmaceuticals.com/role/DerivativesTables </ParentRole>
<Position> 37 </Position>
</Report>
<Report instance="atnm-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R38.htm </HtmlFileName>
<LongName> 038 - Disclosure - Commitments and Contingencies (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/CommitmentsandContingenciesDetails </Role>
<ShortName> Commitments and Contingencies (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://actiniumpharmaceuticals.com/role/CommitmentsandContingenciesTables </ParentRole>
<Position> 38 </Position>
</Report>
<Report instance="atnm-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R39.htm </HtmlFileName>
<LongName> 039 - Disclosure - Commitments and Contingencies (Details 1) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/Commitmentsandcontingenciesdetails1 </Role>
<ShortName> Commitments and Contingencies (Details 1) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://actiniumpharmaceuticals.com/role/CommitmentsandContingenciesTables </ParentRole>
<Position> 39 </Position>
</Report>
<Report instance="atnm-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R40.htm </HtmlFileName>
<LongName> 040 - Disclosure - Commitments and Contingencies (Details Textual) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/Commitmentsandcontingenciesdetailstextual </Role>
<ShortName> Commitments and Contingencies (Details Textual) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://actiniumpharmaceuticals.com/role/CommitmentsandContingenciesTables </ParentRole>
<Position> 40 </Position>
</Report>
<Report instance="atnm-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R41.htm </HtmlFileName>
<LongName> 041 - Disclosure - Equity (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/EquityDetails </Role>
<ShortName> Equity (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://actiniumpharmaceuticals.com/role/EquityTables </ParentRole>
<Position> 41 </Position>
</Report>
<Report instance="atnm-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R42.htm </HtmlFileName>
<LongName> 042 - Disclosure - Equity (Details Textual) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/EquityDetailsTextual </Role>
<ShortName> Equity (Details Textual) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://actiniumpharmaceuticals.com/role/EquityTables </ParentRole>
<Position> 42 </Position>
</Report>
<Report instance="atnm-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R43.htm </HtmlFileName>
<LongName> 043 - Disclosure - Income Taxes (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/IncomeTaxesDetails </Role>
<ShortName> Income Taxes (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://actiniumpharmaceuticals.com/role/IncomeTaxesTables </ParentRole>
<Position> 43 </Position>
</Report>
<Report instance="atnm-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R44.htm </HtmlFileName>
<LongName> 044 - Disclosure - Income Taxes (Details 1) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/IncomeTaxesDetails1 </Role>
<ShortName> Income Taxes (Details 1) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://actiniumpharmaceuticals.com/role/IncomeTaxesTables </ParentRole>
<Position> 44 </Position>
</Report>
<Report instance="atnm-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R45.htm </HtmlFileName>
<LongName> 045 - Disclosure - Income Taxes (Details Textual) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/IncomeTaxesDetailsTextual </Role>
<ShortName> Income Taxes (Details Textual) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://actiniumpharmaceuticals.com/role/IncomeTaxesTables </ParentRole>
<Position> 45 </Position>
</Report>
<Report instance="atnm-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R46.htm </HtmlFileName>
<LongName> 046 - Disclosure - Subsequent Events (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/SubsequentEventsDetails </Role>
<ShortName> Subsequent Events (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://actiniumpharmaceuticals.com/role/SubsequentEvents </ParentRole>
<Position> 46 </Position>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<LongName> All Reports </LongName>
<ReportType> Book </ReportType>
<ShortName> All Reports </ShortName>
</Report>
</MyReports>
<InputFiles>
<File> atnm-20151231.xml </File>
<File> atnm-20151231.xsd </File>
<File> atnm-20151231_cal.xml </File>
<File> atnm-20151231_def.xml </File>
<File> atnm-20151231_lab.xml </File>
<File> atnm-20151231_pre.xml </File>
</InputFiles>
<SupplementalFiles/>
<BaseTaxonomies/>
<HasPresentationLinkbase> true </HasPresentationLinkbase>
<HasCalculationLinkbase> true </HasCalculationLinkbase>
</FilingSummary>

4 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/29/24  Actinium Pharmaceuticals, Inc.    10-K       12/31/23   65:17M                                    EdgarAgents LLC/FA
 3/31/23  Actinium Pharmaceuticals, Inc.    10-K       12/31/22   60:8.1M                                   EdgarAgents LLC/FA
 3/25/22  Actinium Pharmaceuticals, Inc.    10-K       12/31/21   56:4.2M                                   EdgarAgents LLC/FA
 3/31/21  Actinium Pharmaceuticals, Inc.    10-K       12/31/20   56:3.5M                                   EdgarAgents LLC/FA
↑Top
Filing Submission 0001213900-16-011534   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Fri., May 17, 11:38:57.1pm ET